Literature DB >> 10081489

Mutational analyses of multiple target genes in histologically heterogeneous gastric cancer with microsatellite instability.

Y Wang1, K Shinmura, R J Guo, J Isogaki, D Y Wang, I Kino, H Sugimura.   

Abstract

It has been recognized that gastric cancer often shows histological heterogeneity in a single tumor. Although microsatellite instability (MSI) has been reported in gastric cancer, the significance of genomic instability in gastric cancers with histological heterogeneity within a single tumor has never been addressed. We investigated MSI at 8 microsatellite loci in 40 normal/tumor DNA pairs from 20 gastric cancers with histological heterogeneity. Six of 20 patients (10 DNAs of 40 tumor DNAs) had severe MSI in more than 3 loci. Four of the MSI-positive cases had frameshift mutations in the poly(A)10 tract of the TGF beta RII gene. This mutation was found only in the MSI-positive component in the 2 cases (cases 4 and 5) in which only 1 component exhibited MSI. The other 4 cases demonstrated homozygous or heteroclonal mutations (1 and 2 base deletions) in the poly(A)8 tract of the hMSH3 gene; no mutation was detected in the poly(C)8 tract of the hMSH6 gene in any of the MSI-positive cases. The profile of alterations in multiple targets was different between the 2 components in most of the cases (5/6). These findings suggest that mismatch repair deficiency in MSI-positive tumors causes multiple gene inactivations through frameshift mutations in short repetitive sequences in a heterogeneous way within a histologically heterogeneous tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10081489      PMCID: PMC5921733          DOI: 10.1111/j.1349-7006.1998.tb00525.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


microsatellite instability replication error mismatch repair polymerase chain reaction single strand conformational polymorphism transforming growth factor‐β type II receptor insulin‐like growth factor‐II receptor
  36 in total

1.  Evidence of genetic progression in human gastric carcinomas with microsatellite instability.

Authors:  Y J Chung; S W Park; J M Song; K Y Lee; E J Seo; S W Choi; M G Rhyu
Journal:  Oncogene       Date:  1997-10-02       Impact factor: 9.867

2.  Apparent protection from instability of repeat sequences in cancer-related genes in replication error positive gastrointestinal cancers.

Authors:  L A Simms; T T Zou; J Young; Y Q Shi; J Lei; R Appel; M G Rhyu; H Sugimura; G Chenevix-Trench; R F Souza; S J Meltzer; B A Leggett
Journal:  Oncogene       Date:  1997-05-29       Impact factor: 9.867

3.  RER phenotype and its associated mutations in familial gastric cancer.

Authors:  K Shinmura; M Tani; J Isogaki; Y Wang; H Sugimura; J Yokota
Journal:  Carcinogenesis       Date:  1998-02       Impact factor: 4.944

4.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

5.  Genetic instability of microsatellites in endometrial carcinoma.

Authors:  J I Risinger; A Berchuck; M F Kohler; P Watson; H T Lynch; J Boyd
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

6.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

Authors:  H J Han; A Yanagisawa; Y Kato; J G Park; Y Nakamura
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile.

Authors:  R Seruca; N R Santos; L David; M Constância; H Barroca; F Carneiro; M Seixas; P Peltomäki; R Lothe; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1995-02-20       Impact factor: 7.396

8.  Frequent co-occurrence of mutator phenotype in synchronous, independent multiple cancers of the stomach.

Authors:  K Shinmura; H Sugimura; Y Naito; P G Shields; I Kino
Journal:  Carcinogenesis       Date:  1995-12       Impact factor: 4.944

9.  Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.

Authors:  R E Johnson; G K Kovvali; L Prakash; S Prakash
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

10.  Microsatellite instability and loss of heterozygosity in breast cancer.

Authors:  C J Yee; N Roodi; C S Verrier; F F Parl
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

View more
  6 in total

1.  How can research fields be integrated with PET imaging?

Authors:  Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2013-04       Impact factor: 7.370

2.  Editorial: an obsession with subtyping gastric cancer.

Authors:  Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2013-10       Impact factor: 7.370

3.  Regional Bias of Intratumoral Genetic Heterogeneity of Apoptosis-Related Genes BAX, APAF1, and FLASH in Colon Cancers with High Microsatellite Instability.

Authors:  Mi Ryoung Choi; Min Gwak; Nam Jin Yoo; Sug Hyung Lee
Journal:  Dig Dis Sci       Date:  2015-01-20       Impact factor: 3.199

4.  Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography.

Authors:  Hyun Woo Chung; Sun-Young Lee; Hye Seung Han; Hyun Sik Park; Jae Hoon Yang; Hak Hyun Lee; Young So
Journal:  Gastric Cancer       Date:  2012-06-13       Impact factor: 7.370

5.  Intratumor heterogeneity of centromere numerical abnormality in multiple primary gastric cancers: application of fluorescence in situ hybridization with intermittent microwave irradiation on paraffin-embedded tissue.

Authors:  K Kobayashi; Y Kitayama; H Igarashi; G Yoshino; T Kobayashi; T Kazui; H Sugimura
Journal:  Jpn J Cancer Res       Date:  2000-11

6.  Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics.

Authors:  Jiaru Li; Ziyi Yang; Bowen Xin; Yichao Hao; Lisheng Wang; Shaoli Song; Junyan Xu; Xiuying Wang
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.